-
X4 Pharmaceuticals Initiates Pivotal Phase 3 Clinical Trial of Mavorixafor for the Treatment of WHIM Syndrome
Jun 26, 2019, 09:02 AM by Michael CroftCAMBRIDGE, MA, US - Jun 26, 2019 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced the initiation of 4WHIM, a pivotal Phase 3 global clinical trial of mavorixafor (X4P-001) for the treatment of WHIM (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis) syndrome, a rare, inherited, primary immunodeficiency diseaseFull story -
Creative Biolabs Provides Diabody Service to Customers for Research Use
Jun 26, 2019, 02:46 AM by Michael CroftACCORD, NY - Jun 25, 2019 - June 25, 2019, as one of the most successful suppliers in the field of antibody production, Creative Biolabs developed diabody service to customers for both academic and clinical research useFull story -
Genedata Expands Collaboration with AstraZeneca on Deep Learning for High-Content Image Analysis
Jun 25, 2019, 13:24 PM by Michael CroftBASEL, SWITZERLAND - Jun 25, 2019 - Genedata, a leading provider of advanced software solutions for biopharmaceutical R&D, today announced a collaboration with AstraZeneca to automate high-content screening (HCS) image analysis using Genedata Imagence®Full story -
LabTwin’s AI-powered Digital Assistant Now Talks Back and Connects Data Sources in the Lab with New Open API
Jun 25, 2019, 10:37 AM by Michael CroftBERLIN, N/A, GERMANY - Jun 3, 2019 - LabTwin GmbH, the world's first voice and AI-powered digital lab assistant, today announced its new open API that will connect scientists with data sources both inside and outside of the labFull story -
Certara Announces First Recipients of Certara-Monash University Industry Drug Development Fellowships
Jun 25, 2019, 09:43 AM by Michael CroftPRINCETON, NJ - Jun 25, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, and Monash University today announced the recipients of the inaugural Certara-Monash University Industry Drug Development Fellowships – DrFull story -
Sentieon's 'Faster/Cheaper' Genomics Tools
Jun 25, 2019, 08:50 AM by Michael CroftFull storyBio-IT World | Sentieon's DNAseq and TNseq software, are making waves in the life sciences, creating a "drop in replacement" that is a faster and cheaper alternative to the industry standard for secondary analysis in next-generation sequencing (NGS) data processing while producing the industry standard results.
-
Medherant positions itself for the next stage of its development with the appointment of a new CEO
Jun 25, 2019, 06:13 AM by Michael CroftCOVENTRY, UK - Jun 25, 2019 - Medherant Limited (Medherant), the clinical-stage company developing innovative products for pain and CNS diseases using a unique transdermal delivery technology, TEPI Patch®, has appointed John Burt as Chief Executive Officer, effective 24 June 2019Full story -
Creative Proteomics Has Launched a Wide Range of Newly-developed Proteomics Analysis Services for Biologists
Jun 25, 2019, 03:12 AM by Michael CroftSHIRLEY, NY, US - Jun 25, 2019 - Creative Proteomics, a leading supplier in metabolomics services, has recently released its several newly-developed proteomics services to researchersFull story -
Positive Technologies launches PT Application Inspector Enterprise to create secure web applications
Jun 24, 2019, 19:58 PM by Michael CroftFRANGINGHAM, MA, UNITED STATES - Jun 24, 2019 - Positive Technologies today unveiled PT Application Inspector Enterprise (PT AI Enterprise), a solution that automatically detects vulnerabilities and offers security experts the verification tools they need to secure web applicationsFull story -
Tracking The Clinical And Preclinical Progress In Targeting Membrane Proteins
Jun 24, 2019, 11:45 AM by Michael CroftFull storyBio-IT World | G protein-coupled receptors (GPCRs), ion channels, and transporters represent some of the most important drug target classes across a wide range of diseases. According to Catherine Hutchings, progress in targeting these membrane proteins requires a recognition of not only what works, but also what doesn't.
-
Officials Say They Lack Authority To Halt CRISPR Babies Plan In Russia
Jun 24, 2019, 11:35 AM by Michael CroftFull storySTAT | Two influential leaders in science for the first time publicly condemned a Russian biologist who said he plans to produce gene-edited babies but conceded that it was beyond their organizations’ authority to halt him from doing so.
-
CD Genomics Announces Highly Sensitive and Accurate Genome Sequencing Services Related to Genome Research
Jun 24, 2019, 05:59 AM by Michael CroftSHIRLEY, NY - Jun 24, 2019 - SHIRLEY, NY, UNITED STATES – Jun 24, 2019 - CD Genomics, the USA-based genetic sequencing company and an expert in transcriptomics and next generation sequencing, announces the technical escalation of sequencing services, The updated service ranges include five: mitochondrial DNA sequencing, microbial whole genome sequencing, plasmid DNA sequencing, SMRT sequencing and bacterial genome sequencing, which are based on some of the most powerful platforms in this field with unrivaled accuracy and sensitivityFull story -
Steven Daniel joins Cofactor Genomics as Vice President of Business Development
Jun 20, 2019, 15:00 PM by Michael CroftSAN FRANCISCO, CA, UNITED STATES - Jun 20, 2019 - Cofactor Genomics today announced the appointment of Steven Daniel, PhD as Vice President of Business Development, overseeing the development and execution of the companys sales strategy and sales managementFull story -
International Women in Engineering Day 2019: Watson-Marlow Fluid Technology Group partners with Goonhilly Earth Station to inspire next generation of female engineers
Jun 20, 2019, 06:44 AM by Michael CroftFALMOUTH, UK - Jun 20, 2019 - One of the South Wests biggest technology companies, Falmouth-based Watson-Marlow Fluid Technology Group (WMFTG) – part of Spirax-Sarco Engineering plc – will celebrate International Women in Engineering Day (INWED) in partnership with Goonhilly Earth StationFull story -
Scilligence and TetraScience Announce Integration Plan to Automate Research Data
Jun 19, 2019, 20:01 PM by Michael CroftCAMBRIDGE, MA, UNITED STATES - Jun 19, 2019 - Scilligence and TetraScience announce a new integration between their products to automate data management across R&D workflowsFull story -
IBM, KPMG, Merck and Walmart to collaborate as part of FDA’s program to evaluate the use of blockchain to protect pharmaceutical product integrity
Jun 19, 2019, 14:28 PM by Michael CroftNEW YORK, NY, UNITED STATES - Jun 13, 2019 - IBM (NYSE:IBM), KPMG, Merck (NYSE:MRK), and Walmart (NYSE: WMT) today announced that the companies have been selected by the United States Food and Drug Administration (FDA) to be included in a program in support of the UFull story -
Shimmer and ClearSky Announce Partnership to Improve Analysis of Wearable Sensor Data for CNS Diseases
Jun 19, 2019, 08:17 AM by Michael CroftCAMBRIDGE, MA - Jun 19, 2019 - Shimmer Research, a global leader in wearable technology for research applications, and ClearSky Medical Diagnostics, a leader in analyzing wearable data for medical applications, today announced they are partnering to bring a new level of analytic capabilities to the use of wearable sensors in clinical researchFull story -
IDBS E-WorkBook chosen by Solvay for global R&I digital transformation
Jun 19, 2019, 05:43 AM by Michael CroftGUILDFORD, UNITED KINGDOM - Jun 19, 2019 - IDBS' E-WorkBook has been implemented by Solvay, an advanced materials and specialty chemicals company, as part of a digital transformation project that has removed paper-based processes across the organizationFull story -
Aircuity Announces Project with Net Zero Wilde Lake Middle School
Jun 18, 2019, 11:02 AM by Michael Croft, N/A - Jun 18, 2019 - NEWTON, Mass., USA - Aircuity (www.aircuity.com), creator of measurably better environments, announced the installation of its platform at Wilde Lake Middle School in Howard County, MarylandFull story -
Parexel Strengthens Risk-Based Monitoring Offering with CluePoints’ New Advanced Statistical Capabilities
Jun 18, 2019, 09:52 AM by Michael CroftWAYNE, PA - Jun 18, 2019 - Parexel, a leading provider of Clinical, Consulting and Commercial solutions to accelerate the development of innovative new therapies to improve the worlds health, today announced its strategic collaboration with CluePoints, an industry-leading provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software, to enhance overall data quality oversight and ensure regulatory compliance within clinical trialsFull story